Only about 40% of perinatally exposed infants were tested for hepatitis C virus (HCV), and less than 30% of eligible children ...

Please provide your email address to receive an email when new articles are posted on . Measurements taken for HCV cure at 4 weeks produced identical results for people who inject drugs as those taken ...

Insulin resistance is a common extrahepatic manifestation of hepatitis C virus (HCV) infection (HCVi), but its mechanism is ...

A jail-based strategy that includes hepatitis C virus testing, treatment and post-release navigation services could reduce ...

Nontargeted screening in emergency departments (EDs) identified significantly more new hepatitis C virus (HCV) infections than targeted screening, according to a randomized trial. Treatment completion ...

India is among the top ten countries that accounted for 69 per cent of global deaths due to hepatitis B (HBV) in 2024, ...

BANGKOK, April 28 (Xinhua) -- Global action against viral hepatitis has yielded tangible progress, yet the current progress is still falling short of the 2030 elimination targets, the World Health ...

In the wake of recent breakthroughs in the management of hepatitis C virus (HCV) infection, with several new promising medications available on the market and more being studied in clinical trials, it ...

Hepatitis C is one of the most common viral infections in the United States. Without treatment, hepatitis C can lead to severe health issues. Epclusa was approved to treat chronic hepatitis C by the ...

In this Forefront article, we explore some of the critical policy and economic considerations embedded in the Cure Hepatitis C Act of 2025, highlighting the choices policy makers face in converting a ...

Atea Pharmaceuticals announced the ongoing enrollment in its Phase 3 C-BEYOND trial evaluating the combination of bemnifosbuvir and ruzasvir for the treatment of hepatitis C virus (HCV). Positive ...

Asymptomatic disease and early progression. The progression of HCV infection to cirrhosis is often asymptomatic and clinically silent. In chronic hepatitis, the correlation of biochemical liver ...